Although renin-independent hypermineralocorticoidism is an uncommon fo
rm of hypertension, its diagnosis provides the clinician with a unique
opportunity in the field of hypertension that is, to vender a surgica
l cure or to achieve a dramatic pharmacologic response in the treatmen
t of hypertension. Primary aldosteronism is the most common form of re
nin-independent hypermineralocorticoidism. The plasma aldosterone conc
entration to plasma renin ratio is an excellent screening test for pri
mary aldosteronism, the diagnosis of which should be confirmed by demo
nstrating unsuppressible urine or plasma levels of aldosterone. The su
btype of primary aldosteronism dictates the most appropriate therapy.
Computerized imaging of the adrenal glands and adrenal venous sampling
assist in distinguishing unilateral (requiring surgical treatment) fr
om bilateral (requiring pharmacologic treatment) adrenal disease. The
forms of mineralocorticoid excess considered in the hypokalemic hypert
ensive patient with low aldosterone values include congenital adrenal
hyperplasia (11 beta-hydroxylase and 17 alpha-hydroxylase deficiencies
), deoxycorticosterone-producing tumor Cushing's syndrome, primary cor
tisol resistance, and 11 beta-hydroxysteroid dehydrogenase deficiency
(apparent mineralocorticoid excess syndrome). The 11 beta-hydroxystero
id dehydrogenase deficiency may be congenital or acquired (for example
, ingestion of licorice or carbenoxolone).